Gadolinium Neutron Capture Therapy Influences Colon Microbiota in Experimental Breast Cancer.
1/5 보강
Quantitative differences in isolated microorganisms were determined using the culture-based analysis of fecal microbiota.
APA
Kabakov AV, Kazakov OV, et al. (2026). Gadolinium Neutron Capture Therapy Influences Colon Microbiota in Experimental Breast Cancer.. Bulletin of experimental biology and medicine, 180(3), 363-366. https://doi.org/10.1007/s10517-026-06638-5
MLA
Kabakov AV, et al.. "Gadolinium Neutron Capture Therapy Influences Colon Microbiota in Experimental Breast Cancer.." Bulletin of experimental biology and medicine, vol. 180, no. 3, 2026, pp. 363-366.
PMID
41944935 ↗
Abstract 한글 요약
Quantitative differences in isolated microorganisms were determined using the culture-based analysis of fecal microbiota. In female rats with untreated breast cancer, the abundance of typical Escherichia coli, Bifidobacterium spp., and Lactobacillus spp. decreased in comparison with the group intact of animals and no opportunistic enterobacteria Enterobacter cloacae and Enterococcus spp. were detected in cultures. After gadolinium neutron capture therapy, the abundance of typical E. coli, Bacillus subtilis, and Bifidobacterium spp. decreased, and there was no culture growth of the opportunistic enterobacteria Enterobacter cloacae and Enterococcus spp. in comparison with intact animals. The abundance of Lactobacillus spp. increased to a level of intact control.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- SpNeigh: spatial neighborhood and differential expression analysis for high-resolution spatial transcriptomics.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review.